H.C. Wainwright analyst Raghuram Selvaraju reiterated a Neutral rating on Kezer Life Sciences (NASDAQ: KZR).The analyst commented: "Late last week ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE